A search for synergy in the binding kinetics of Trastuzumab and Pertuzumab whole and F(ab) to Her2

Therapeutic efficacy resulting from combining Trastuzumab and Pertuzumab in the treatment of Her2 overexpressing breast cancer patients has been shown to increase patient survival. This is thought to arise from inhibition of receptor dimerization and the immune tagging of the cancer cells; however,...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:NPJ Breast Cancer
मुख्य लेखकों: Lua, Wai-Heng, Gan, Samuel Ken-En, Lane, David Philip, Verma, Chandra Shekhar
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2015
विषय:
Brief Communication
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5515203/
https://ncbi.nlm.nih.gov/pubmed/28721368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjbcancer.2015.12
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन